Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL ConsortiumLijuan Deng, Ken H. Young, L Zhang et al.|Leukemia|2015Cited by 83
Highly efficient blue-emitting silicate phosphor BaY4Si5O17:Eu2+ with superior thermal stability for full-visible-spectrum white LEDsMaoli Wang, Rui Zhang, Lijuan Xiao et al.|Optical Materials|2024Cited by 10
Long-term outcomes with HLX01 (HanliKang®), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 studyYuankai Shi, Yongping Song, Dong Wang et al.|BMC Cancer|2024Cited by 4
A phase 1 study of lucar-G39D: A novel anti-CD20/CD19 dual-CAR allogeneic gamma delta T cells in adults with relapsed / refractory B-cell non-Hodgkin lymphoma (NHL)Jingwei Yu, Huilai Zhang, Linlin Cao et al.|Blood|2025Cited by 0